Association of Reference Pricing with Drug Selection and Spending

In the United States, the pharmaceutical market has an increasing potential for cost-reducing competition, as manufacturers launch branded, generic, and biosimilar products that have safety and efficacy profiles equivalent to existing treatments. However, potential competition will translate into…

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2wS9QcX